Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes

Virology

Volumn 273, Issue 2, 2000, Pages 374-382

  Wen Jun Liu, ^a   Xiao Song Liu, ^a   Kong Nan Zhao, ^a   Leggatt, G R ^a   Frazer, I H ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; VIRUS PROTEIN;

ANTIBODY RESPONSE; ARTICLE; CHIMERA; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WART VIRUS;

BOVINAE; BOVINE PAPILLOMAVIRUS; BOVINE PAPILLOMAVIRUS TYPE 1; DNA VIRUSES; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; UNIDENTIFIED BACULOVIRUS;

EID: 0034254994     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0435     Document Type: Article

References (44)

1. A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen
2. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants
3. Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papilloma-virus
4. Identification of the alpha6 integrin as a candidate receptor for papillomaviruses
5. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells
6. Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papilloma-virus type 16-induced tumors
7. Vaccine-induced Th1-type responses are dominant over Th2-type responses in the short term whereas pre-existing Th2 responses are dominant in the longer term
8. A protein particle vaccine containing multiple malaria epitopes
9. Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model
10. Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: Induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion
11. DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: Immunogenicity in mice
12. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization
13. Type specific and genotype cross reactive B epitopes of the L1 protein of HPV16 defined by a panel of monoclonal antibodies
14. Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice
15. Human papillomavirus type II (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast
16. An HLA-A2 polyepitope vaccine for melanoma immunotherapy
17. Cytotoxic T-cells immunity to influenza
18. Recombinant hepatitis B surface antigen as a carrier of human immunodeficiency virus epitopes
19. Papillomavirus capsid binding and uptake by cells from different tissues and species
20. Chimeric papillomavirus-like particles
21. Mucosal but not parenteral immunization with purified human papillomvirus type 16 virus-like particles induces neutralizing titers of antibodies throughout the estrous cycle of mice
22. Carboxyl terminus of bovine papillomavirus type-1 L1 protein is not required for capsid formation
23. Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway
24. Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseases
25. Epithelial cells display separate receptors for papillomavirus VLPs and for soluble L1 capsid protein
26. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype
27. Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptor
28. DNA immunization with minigenes: Low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination
29. Induction of protective cytotoxic T cells to murine cytomegalovirus by using a nonapeptide and a human-compatible adjuvant (Montanide ISA 720)
30. Immune response to human papillomavirus 16 L1 E7 chimeric virus-like particles: Induction of cytotoxic T cells and specific tumor protection
31. Recombinant parvovirus-like particles as an antigen carrier: A novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells
32. Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity
33. Multi-epitope DNA vaccines
34. Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes
35. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination
36. A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants
37. Chimeric hepatitis B core antigen particles containing B-and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised mice
38. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans
39. + cytotoxic T-cell epitopes
40. Antibodies to Schistosoma japonicum (Asian bloodfluke) paramyosin induced by nucleic acid vaccination
41. HPV6b virus like particles are potent immunogens without adjuvant in man
42. Identification of the nuclear localization signal of human papillomavirus type 16 L1 protein
43. Early phase in the infection of cultured cells with papillomavirus virions
44. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles